Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Driving fitness under Silexan compared with placebo and lorazepam
ISRCTN32209377Phase 2Completed
- Sponsor
- Schwabe Group
- Start
- Mar 2016
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of Silexan and lorazepam, sponsored by Schwabe Group. Started Mar 2016; status: completed.
02
Drugs
Silexanlorazepam
Beyond the preview
Go deeper on ISRCTN32209377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN32209377.